Capital Formation

The biotech industry has shrunk dramatically in recent years based primarily on the continued tight capital markets and increased aversion to risk on the part of investors.

What is your opinion of biotechnology companies – very favorable, somewhat favorable, somewhat unfavorable, or very unfavorable?

Mankind's need to cure disease, combat hunger and discover new forms of energy has never been more urgent.

BIOtechNOW’s Tracy Cooley talks to Dr. Schubert of the  Bioscience Association of West Virginia about biotech in West Virginia – major areas of growth, the outlook for growth of the industry within the states, and plans for the upcoming  BIO International Convention.

Biofuels Digest and BIO have launched the Summer 2011 Bioenergy Business Outlook Survey.

BIO and five member companies – Mendel Biotechnology, Arborgen, Abengoa Bioenergy, Novozymes and BP Biofuels – along with the Biomass Power Association held a briefing on Capitol Hill this week, outlining the importance of the USDA’s Biomass Crop Assistance Program (BCAP) and related programs. Regulatory rules for the BCAP, Biorefinery Assistance Program, and Rural Energy for America Program (REAP) were finalized by USDA only during the last quarter of 2010. But Congress is considering cutting the funds for these programs before they have a chance to show their effectiveness.

The Biotechnology Entrepreneurship Boot Camp at the 2011 BIO International Convention is an intensive three day course designed for entrepreneurial scientists.

The Biotechnology Entrepreneurship Boot Camp at the 2011 BIO International convention is an intensive three day course designed for entrepreneurial scientists, CEOs, CSOs and business development professionals of early stage companies in the life sciences who are aspiring entrepreneurs.

The Biotechnology Entrepreneurship Boot Camp at the 2011 BIO International convention is an intensive three day course designed for entrepreneurial scientists, CEOs, CSOs and business development professionals of early stage companies in the life sciences who are aspiring entrepreneurs.

Fine, University of Maryland Dingman Center for Entrepreneurship and local co-chair of the Boot Camp, discusses the event, who should attend and what they can expect to learn.

WASHINGTON, D.C. (Tuesday, April 19, 2011) - The Biotechnology Industry Organization (BIO) announced today that Dr. Jörg Reinhardt, CEO of Bayer HealthCare, will provide the keynote address at the BIO China International Conference to be held October 12-13 in Shanghai, China. The event will bring together biotechnology and pharmaceutical leaders to explore business opportunities with life science companies in China.

This week is National Small Business Week (May 16-20). Every year, the president proclaims National Small Business Week to recognize the contributions of small businesses to the economic well-being of America. More than half of all Americans either own or work for a small business. In honor of National Small Business Week, BIO compiled our top 5 strategies for small business success.

Emerging biotech companies with promising scientific innovation need a policy environment that will enable them to continue critical research and development of medical advancements and breakthroughs.

Multiple sclerosis (MS) is a complex disease involving immune-system attacks on the central nervous system. Research into MS involves questions that dovetail many fields of science, including immunology, neuroscience, psychology and more.

Letters, Testimony & Comments

July 26 2012
Jeffrey S. Hatfield, President and Chief Executive Officer, Vitae Pharmaceuticals On behalf of the Biotechnology Industry...
March 16 2012
Dear Majority Leader Reid and Minority Leader McConnell: On behalf of the Biotechnology Industry Organization (BIO) and its more than 1...
March 6 2012
William D. Waddill, Senior Vice President and Chief Financial Officer OncoMed Pharmaceuticals highlights the importance of capital...
December 1 2011
On December 1, BIO submitted written testimony to the Senate Committee on Banking, Housing, and Urban Affairs on the importance of...
April 7 2011
Hearing Testimony Scott Koenig, M.D., PH.D. Before the House of Representatives Committee on Small Business Good morning Chairman...

Press Releases

June 6 2012
Washington, DC and New York, NY, Wednesday, June 6, 2012 -The 4th Annual Scientific American Worldview Report and...
April 5 2012
Washington, D.C. (April 5, 2012) – The Biotechnology Industry Organization expressed strong support for the...
March 22 2012
  Washington, DC (March 22, 2012) – The Biotechnology Industry Organization (BIO) applauds the Senate...
December 6 2011
Washington, DC (December 6, 2011) – The Biotechnology Industry Organization (BIO) announces program topics...
November 16 2011
Self-Funding Program Supported by Leading Biotech Trade Associations WASHINGTON, D.C. (November 16, 2011)...